Impact Events
MoreDate | Lead Company | Event | Type | Approval Change | Approval Likelihood |
---|---|---|---|---|---|
4/15/24 | Roche (RHHBY) | Columvi for Diffuse Large B-Cell Lymphoma (DLBCL) - NHL | Subscribers Only | Subscribers Only | Subscribers Only |
4/9/24 | Fusion (FUSN) | FPI-2265 for Prostate Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
4/9/24 | Pfizer (PFE) | Abrysvo for Respiratory Syncytial Virus (RSV) Prevention | Subscribers Only | Subscribers Only | Subscribers Only |
4/9/24 | BeiGene (BGNE) | BGB-A1217 for Small Cell Lung Cancer (SCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
4/8/24 | Organon (OGN) | HLX-14 for Osteoporosis / Osteopenia | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
MoreExpected Date Range | Lead Company | Drug | Expected Catalyst |
---|---|---|---|
03/01/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
03/19/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
04/09/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
04/15/24 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
04/15/24 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |